Skip to content

Doro Mind

8 viewers · 30d

Total raised

$4.7M

+$4.7M this year

1 filing since 2026 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $4.7M
ROUNDS
1
INVESTORS
14
FOUNDED
2023
HQ
Albany, NY
SECTOR
Other Technology
EMPLOYEES
N/A
30D VIEWERS
8

AI overview

Updated

Doro Mind is a public benefit corporation that provides compassionate, accessible support for individuals recovering from psychosis and their families. The company offers a team-based, personalized care model that emphasizes expert clozapine management, family involvement, and long-term recovery. It aims to fill critical gaps in post-hospitalization support and care navigation for conditions like schizophrenia, schizoaffective disorder, and bipolar-1.

What sets it apart

The company is distinguished by its founder-driven mission, stemming from personal family experiences with psychosis recovery, and its specialized focus on a slow, expert-led clozapine titration protocol developed by its Medical Director, Dr. Robert Laitman. Its public benefit structure legally embeds its mission to prioritize patient recovery.

Funding history

1 round
EquityFeb 11, 2026
Form D
+$4.7M$4.7M total

Latest SEC filings

via EDGAR · CIK 0002008487
Form D · Feb 11, 2026View on EDGAR

Products

1 tracked

Doro Compass

Care Consulting & Education

Doro Compass is a national, membership-based consulting and education program designed to augment an individual's existing care team. It provides expert guidance, coaching, and support for adults with psychosis and their family caregivers across the United States. The service is delivered virtually and is focused on education and navigation rather than direct clinical treatment.

  • Expert clozapine management guidance
  • Assistance with identifying local providers
  • Educational coaching sessions
  • Virtual support groups for members and families

Links

WebsiteSEC EDGAR filings